MEDICAMEQ.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Stats
Tagesvolumen	149 877
Durchschnittsvolumen	42 578.00
Marktkapitalisierung	6.15B
EPS	INR0 ( 2024-02-11 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-27
Last Dividend	INR1.000 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	53.80
ATR14	INR2.50 (0.51%)

Volumen Korrelation

Lang: 0.65 (weak)

Kurz: -0.81 (strong negative)

Signal:(49.921) Neutral

Medicamen Biotech Limited Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Medicamen Biotech Limited Korrelation - Währung/Rohstoff

0.37
( neutral )

-0.47
( neutral )

-0.72
( moderate negative )

-0.30
( neutral )

-0.02
( neutral )

0.94
( very strong )

Medicamen Biotech Limited Finanzdaten

Annual	2022
Umsatz:	INR1.41B
Bruttogewinn:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Umsatz:	INR1.41B
Bruttogewinn:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Umsatz:	INR1.15B
Bruttogewinn:	INR479.88M (41.57 %)
EPS:	INR12.19

FY	2021
Umsatz:	INR1.13B
Bruttogewinn:	INR335.16M (29.74 %)
EPS:	INR9.93

Financial Reports:

No articles found.

Medicamen Biotech Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Medicamen Biotech Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.57 - low (18.86%) | Divividend Growth Potential Score: 2.46 - Decrease likely (50.81%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2022-09-19
Last Dividend	INR1.000	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.02%	--
Score	1.43	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	2.46
Div. Directional Score	3.02	--

Next Divdend (Est)
(2024-04-28)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR1.000	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUPRIYA.NS	Dividend Junior	2023-09-15	Annually	3	0.10%
NCLIND.NS	Dividend Junior	2023-09-15	Semi-Annually	18	1.25%
ICEMAKE.NS	No Dividend Player	2023-09-14	Annually	7	0.81%
CDSL.NS	Dividend Junior	2023-08-25	Annually	7	0.92%
RPPL.NS	Dividend Junior	2023-08-24	Annually	6	0.31%
LIKHITHA.NS	Dividend Junior	2023-09-20	Annually	4	0.46%
GANESHHOUC.NS	Dividend Junior	2023-08-31	Sporadic	18	0.18%
APTUS.NS	Dividend Junior	2023-05-12	Semi-Annually	3	0.32%
TECHNOE.NS	Dividend Junior	2023-09-15	Annually	16	1.13%
ONGC.NS	Dividend Knight	2023-08-18	Semi-Annually	28	4.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0671	1.500	8.66	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0582	1.500	-0.464	-0.696	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.27	1.000	9.16	9.16	[3 - 30]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.97	2.00	4.51	9.03	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.469	1.000	5.52	5.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	53.67	1.000	4.68	0	[1 - 100]
returnOnEquityTTM	0.0582	2.50	-0.298	-0.696	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.97	2.00	6.34	9.03	[0 - 30]
dividendYielPercentageTTM	0.206	1.500	4.85	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.115	1.500	-4.10	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0814	1.000	-0.466	0	[0.1 - 0.5]
Total Score				2.46

Medicamen Biotech Limited

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.